The Morality of Everyday Things: An Everyday Philosophy Podcast · Ant and Jake

Is it wrong to increase the price of medicine?

·43 min·15 clips
Jake and Ant begin with Daraprim, the drug used to treat toxoplasmosis that became notorious after its price jumped from $13.50 to $7.50 per pill. They use that story as the doorway into the larger question of what medicine should cost. The conversation stays casual and argumentative, with the hosts checking each other's assumptions as they go. They spend time on the idea that moral judgment is not always as simple as calling something expensive or unfair. The episode leans into the limits of capitalism. It asks whether the profit incentive is enough to justify how medical research and healthcare are organized. The hosts compare medicine with public goods like street lighting to suggest that some things are awkward or impossible to price cleanly. They also point to the way governments can act on problems that matter to most people over the mid to long term. That leads into a broader critique of markets as the default answer to everything. The discussion touches on how profit can concentrate attention on narrow, high-paying customers instead of shared social needs. One example raised is the possibility of private money chasing life extension for billionaires. The hosts treat that as a useful warning sign, not as a punchline. They also bring in the Heinz experiment and social development as part of the moral framing. The episode keeps moving between abstract principle and everyday analogy. It does not settle for slogans about free markets or public ownership. Instead it keeps asking what kinds of decisions should be left to price, and what kinds should be treated as collective responsibilities. The tone stays dry, curious, and a little skeptical throughout. The hosts are comfortable admitting where the line is blurry. They return again and again to the same basic problem: when a medicine is necessary, does ordinary market logic still make sense? The episode ends with the sense that the argument is still open, even if the hosts have pushed it a long way.

As heard by us

A lively ethics debate that turns a notorious price hike into a wider argument about what medicine should cost.

Daraprim is the setup, but the episode keeps widening until it becomes a sharper argument about what happens when medicine, profit, and basic fairness collide.

Read the full review in PlayNext →

Why you'd press play

You want an ethics debate built around the Daraprim price hike and the question of how much medicine should cost.

Read the full recommendation in PlayNext →
Listen to the show on